Practical help in 4 modules
Module 1 – Webinar – Now available On Demand
Understanding the issues around the GLP-1 RA shortage
- Understanding the impact of the current GLP-1 RA shortage
- Making sense of the guidance published
- Identifying and prioritising those affected
- Practical resources to support clinicians
Plus downloadable guides:
 |
Module 2 – Webinar – Now available On Demand
Tackling the GLP-1 RA shortage in clinical practice: A consultation guide
- Applying national guidance in practice
- Promoting patient-centred discussion
- Identifying appropriate alternatives to GLP-1 RAs
- Working through practical case examples
Plus downloadable guides:
|
Module 3 – Common patient scenarios
Now available on demand
 |
|
 |
|
Module 4 – Webinar
Where are we now?
Monday, 13th November 2023, 19:00 hours
 |
|
You must be an Issues & Answers member* to register for this programme, login below:
*If you are not already a member click here to register for FREE.
Your expert panel
Jane DiggleSpecialist Diabetes Nurse Practitioner, West Yorkshire.
Dr Pam BrownGP, Swansea.
Nicola MilnePCN DiAST Lead & PCN Manchester.
Hannah BebaConsultant Pharmacist: Diabetes, Leeds
Click on the links below to view the notifications published by the Department of Health & Social Care, plus the guidance document from ABCD & PCDS:
Medicine Supply Notification (MSN/2023/061)
National Patient Safety Alert: Shortage of GLP-1 receptor agonists
Guidance from ABCD & PCDS: GLP-1 RA National Shortage
This educational programme has been supported by:
This educational programme has been independently sponsored by the Boehringer Ingelheim and Lilly (BI & Lilly) Alliance. The BI & Lilly Alliance has had no control or input into the educational content of this programme, choice of speakers, nor the opportunity to influence presentations.
The content, opinions and statements made in this programme are those of the presenters and do not necessarily reflect the views of the supporters, editors or editorial board
